Leila Dorling

2.2k total citations
18 papers, 541 citations indexed

About

Leila Dorling is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Leila Dorling has authored 18 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Leila Dorling's work include BRCA gene mutations in cancer (7 papers), Global Cancer Incidence and Screening (5 papers) and Genetic factors in colorectal cancer (4 papers). Leila Dorling is often cited by papers focused on BRCA gene mutations in cancer (7 papers), Global Cancer Incidence and Screening (5 papers) and Genetic factors in colorectal cancer (4 papers). Leila Dorling collaborates with scholars based in United Kingdom, Spain and Netherlands. Leila Dorling's co-authors include N.G. Burnet, Gillian C. Barnett, Charlotte E. Coles, Gordon Wishart, Jennifer Wilkinson, A.M. Moody, Mukesh B. Mukesh, Charles B. Wilson, N. Twyman and Wendi Qian and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Leila Dorling

16 papers receiving 531 citations

Peers

Leila Dorling
Christopher A. Peters United States
Andrea Marshall United Kingdom
Navita Somaiah United Kingdom
Trine Grantzau Denmark
Evan C. Osmundson United States
Adam Currey United States
Lise Bech Jellesmark Thorsen Denmark
Zhaozhi Yang China
Roger Owen United Kingdom
Cheng‐Bo Han China
Christopher A. Peters United States
Leila Dorling
Citations per year, relative to Leila Dorling Leila Dorling (= 1×) peers Christopher A. Peters

Countries citing papers authored by Leila Dorling

Since Specialization
Citations

This map shows the geographic impact of Leila Dorling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Dorling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Dorling more than expected).

Fields of papers citing papers by Leila Dorling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Dorling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Dorling. The network helps show where Leila Dorling may publish in the future.

Co-authorship network of co-authors of Leila Dorling

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Dorling. A scholar is included among the top collaborators of Leila Dorling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Dorling. Leila Dorling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mukhtar, Toqir K, Leila Dorling, Xin Yang, et al.. (2025). Associations between ATM c.7271T>G and cancer risk: analysis of Breast Cancer Association Consortium and UK Biobank data. Journal of Medical Genetics. 62(9). 547–550.
2.
Loizidou, Maria A., Leila Dorling, Joe Dennis, et al.. (2023). Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls. Frontiers in Genetics. 14. 1248492–1248492. 1 indexed citations
3.
Li, Shuai, Robert J. MacInnis, Andrew Lee, et al.. (2022). Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. The American Journal of Human Genetics. 109(10). 1777–1788. 8 indexed citations
4.
Yang, Xin, Mikael Eriksson, Kamila Czene, et al.. (2022). Validation of the BOADICEA  Multifactorial Breast Cancer Risk Prediction Model in a Large Prospective Study. SSRN Electronic Journal. 1 indexed citations
5.
Yang, Xin, Mikael Eriksson, Kamila Czene, et al.. (2022). Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. Journal of Medical Genetics. 59(12). 1196–1205. 41 indexed citations
6.
Bueno‐Martínez, Elena, Sara Carvalho, Jamie Allen, et al.. (2021). Splicing predictions, minigene analyses, and ACMG‐AMP clinical classification of 42 germline PALB2 splice‐site variants. The Journal of Pathology. 256(3). 321–334. 16 indexed citations
7.
Naderi, Elnaz, Laura Fachal, Leila Dorling, et al.. (2020). A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis.. Apollo (University of Cambridge). 12 indexed citations
8.
Li, Jingmei, Wei Wen, Brennan Decker, et al.. (2018). Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer. Cancer Research. 78(21). 6329–6338. 16 indexed citations
9.
Fachal, Laura, Leila Dorling, Gill Barnett, et al.. (2018). Meta-Analysis of Genome-Wide Association Studies (GWAS) of Late Toxicity in 3,874 Men Treated with Radiation for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). e738–e739.
10.
Benusiglio, Patrick R., et al.. (2016). Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling. Familial Cancer. 16(1). 51–56. 18 indexed citations
11.
Ahmed, Mahbubl, Leila Dorling, Sarah L. Kerns, et al.. (2016). Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. British Journal of Cancer. 114(10). 1165–1174. 18 indexed citations
12.
Dorling, Leila, Siddhartha Kar, Kyriaki Michailidou, et al.. (2016). The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study. PLoS ONE. 11(7). e0158984–e0158984. 8 indexed citations
13.
Dorling, Leila, Gillian C. Barnett, Kyriaki Michailidou, et al.. (2015). Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity. Clinical Cancer Research. 22(6). 1413–1420. 15 indexed citations
14.
15.
Abraham, Jean, Qi Guo, Leila Dorling, et al.. (2014). Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel. Clinical Cancer Research. 20(9). 2466–2475. 82 indexed citations
16.
Mukesh, Mukesh B., Wendi Qian, Jennifer Wilkinson, et al.. (2014). Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: Results from the Cambridge Breast IMRT trial. Radiotherapy and Oncology. 111(2). 270–275. 30 indexed citations
17.
Fachal, Laura, Antonio Gómez‐Caamaño, Gillian C. Barnett, et al.. (2014). A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nature Genetics. 46(8). 891–894. 101 indexed citations
18.
Mukesh, Mukesh B., Gillian C. Barnett, Jennifer Wilkinson, et al.. (2013). Randomized Controlled Trial of Intensity-Modulated Radiotherapy for Early Breast Cancer: 5-Year Results Confirm Superior Overall Cosmesis. Journal of Clinical Oncology. 31(36). 4488–4495. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher A. Peters Breakdown of academic impact, for papers by Andrea Marshall Breakdown of academic impact, for papers by Navita Somaiah Breakdown of academic impact, for papers by Trine Grantzau Breakdown of academic impact, for papers by Evan C. Osmundson Breakdown of academic impact, for papers by Adam Currey Breakdown of academic impact, for papers by Lise Bech Jellesmark Thorsen Breakdown of academic impact, for papers by Zhaozhi Yang Breakdown of academic impact, for papers by Roger Owen Breakdown of academic impact, for papers by Cheng‐Bo Han
Rankless by CCL
2026